Pelletier, Jean-Pierre
Raynauld, Jean-Pierre
Abram, François
Dorais, Marc
Delorme, Philippe
Martel-Pelletier, Johanne
Funding for this research was provided by:
This initiative was funded by a grant from Sanofi Canada
Article History
Received: 6 December 2017
Accepted: 5 February 2018
First Online: 1 March 2018
Ethics approval and consent to participate
: Data analyzed in this study are from the Osteoarthritis Initiative (OAI) (see Funding for cohort description). Ethics approval was obtained by each OAI clinical site (University of Maryland Baltimore—Institutional Review Board, Ohio State University’s Biomedical Sciences Institutional Review Board, University of Pittsburgh Institutional Review Board, and Memorial Hospital of Rhode Island Institutional Review Board) and the OAI coordinating center (Committee on Human Research at University of California, San Francisco, CA, USA). All patients provided written informed consent for participation in the OAI.
: Not applicable.
: J-PP is a shareholder in ArthroLab and consultant for Sanofi Canada. J-PR is a consultant for ArthroLab and Sanofi Canada. FA is an employee of ArthroLab. MD is a consultant for ArthroLab. PD is an employee of ArthroLab. JM-P is a shareholder in ArthroLab and consultant for Sanofi Canada.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.